Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2019 Dec;8(Suppl 4):S391-S394.
doi: 10.21037/tlcr.2019.09.09.

Minimal residual disease after radical surgery in EGFR-mutant non-small cell lung cancer

Katsuhiro Masago  1 , Yoshitsugu Horio  2 , Shiro Fujita  1 , Yasushi Yatabe  1   3
Affiliations
Editorial

Minimal residual disease after radical surgery in EGFR-mutant non-small cell lung cancer

Katsuhiro Masago et al. Transl Lung Cancer Res. 2019 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Comment in

Comment on

References

    1. Zhong WZ, Wang Q, Mao WM, et al. Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II-IIIA (N1-N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study. Lancet Oncol 2018;19:139-48. 10.1016/S1470-2045(17)30729-5 - DOI - PubMed
    1. Xu ST, Xi JJ, Zhong WZ, et al. The Unique Spatial-Temporal Treatment Failure Patterns of Adjuvant Gefitinib Therapy: A Post Hoc Analysis of the ADJUVANT Trial (CTONG 1104). J Thorac Oncol 2019;14:503-12. 10.1016/j.jtho.2018.11.020 - DOI - PubMed
    1. Togashi Y, Masago K, Masuda S, et al. Cerebrospinal fluid concentration of gefitinib and erlotinib in patients with non-small cell lung cancer. Cancer Chemother Pharmacol 2012;70:399-405. 10.1007/s00280-012-1929-4 - DOI - PubMed
    1. Mouchard-Delmas C, Gourdier B, Vistelle R, et al. Modification of the blood-brain barrier permeability by vinorelbine: effect of intracarotid infusion compared with intravenous infusion. Anticancer Drugs 1996;7:213-9. 10.1097/00001813-199602000-00011 - DOI - PubMed
    1. Laurell G, Andersson A, Engstrom B, et al. Distribution of cisplatin in perilymph and cerebrospinal fluid after intravenous administration in the guinea pig. Cancer Chemother Pharmacol 1995;36:83-6. 10.1007/BF00685738 - DOI - PubMed